Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2025-03 · 45 (3) · 169-176
DOI: 10.1002/phar.70004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 04.03.2025. Verfasst von Trisha Matsuura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Hyponatremia, Selective Serotonin Reuptake Inhibitors, Sodium Chloride Symporter Inhibitors. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Objective
Hyponatremia is a common electrolyte disorder among older adults that can cause serious adverse effects. The purpose of this study was to assess the risk of hyponatremia with the concurrent use of selective serotonin reuptake inhibitors (SSRIs) and thiazide diuretics in an older population.
Methods
Two retrospective nested case–control studies were conducted with exposure to an SSRI or a thiazide diuretic. Persons of interest were those enrolled in Medicare and who received parts A, B, and D benefits from 2017 to 2019 and who were receiving either an SSRI or thiazide diuretic. Cases were individuals with a diagnosis of hyponatremia. Controls had no documented history of hyponatremia. A logistic regression was conducted to determine the odds of hyponatremia.
Results
Of the 551,298 patients receiving a SSRIs, the mean age was 77.8 years (Standard Deviation ( SD ) ± 8.0 years), 69% were female, and 91.23% were classified as White. We identified 701,007 individuals receiving a thiazide diuretic, with a mean age of 77.1 years ( SD ± 7.2 years), 60.2% female, and 82.72% White. The prevalence of hyponatremia was 10.4% in patients taking thiazides alone and 9.0% in those taking SSRIs alone. On the other hand, patients on both medications had a hyponatremia prevalence of approximately 13.0%. Among SSRI users, the adjusted odds ratio (OR) of hyponatremia with concomitant use of thiazide diuretics was 1.24 (95% Confidence Interval (CI): 1.22–1.26). For thiazide users, the adjusted OR of hyponatremia with exposure to SSRIs was 1.27 (95% CI:1.24–1.29).
Conclusion
The concurrent use of thiazide diuretics and SSRIs is associated with an increased risk of hyponatremia in older populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA.
- School of Pharmacy, University of Washington, Seattle, Washington, USA.
ORCID-Profile: Abdelrahaman G Tawfik, Kenechukwu C Ben-Umeh, Philip D Hansten, Daniel C Malone
Zitieren
APA
Matsuura, T., Tawfik, A. G., Ben-Umeh, K. C., Hansten, P. D., & Malone, D. C. (2025). Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 45(3), 169-176. https://doi.org/10.1002/phar.70004
Vancouver
Matsuura T, Tawfik AG, Ben-Umeh KC, Hansten PD, Malone DC. Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2025;45(3):169-176. doi:10.1002/phar.70004
BibTeX
@article{Matsuura2025,
author = {Matsuura, Trisha and Tawfik, Abdelrahaman G and Ben-Umeh, Kenechukwu C and Hansten, Philip D and Malone, Daniel C},
title = {Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2025},
volume = {45},
number = {3},
pages = {169--176},
doi = {10.1002/phar.70004}
}
EUVIMED